Table 3. Doppler parameters of the studied groups.
Group I | Group II | T | P value | |
---|---|---|---|---|
PVD (Normal < 13 mm) | ||||
Baseline | 13.210 ± 2.353 | 14.805 ± 2.528 | -2.065 | 0.046* |
30 days after | 13.440 ± 2.204 | 14.265 ± 2.209 | -1.182 | 0.244 |
P value | 0.306 | 0.192 | ||
PVV (15.5 ± 4.0 cm/sec) | ||||
Baseline | 9.025 ± 2.400 | 8.915 ± 2.199 | 0.151 | 0.881 |
30 days after | 9.470 ± 2.202 | 8.513 ± 2.714 | 1.225 | 0.228 |
P value | 0.358 | 0.424 | ||
PVFV (0.864 ± 0.188
L/min) |
||||
Baseline | 0.548 ± 0.284 | 0.557 ± 0.358 | -0.088 | 0.930 |
30 days after | 0.641 ± 0.367 | 0.510 ± 0.338 | 1.175 | 0.247 |
P value | 0.180 | 0.630 | ||
HARI (0.55–0.7) | ||||
Baseline | 0.785 ± 0.088 | 0.739 ± 0.079 | 1.748 | 0.088 |
30 days after | 0.717 ± 0.086 | 0.757 ± 0.088 | -1.455 | 0.154 |
P value | < 0.001* | 0.478 | ||
HAPI (0.92 ± 0.1) | ||||
Baseline | 1.544 ± 0.553 | 1.524 ± 0.403 | 0.134 | 0.894 |
30 days after | 1.410 ± 0.348 | 1.609 ± 0.446 | -1.573 | 0.124 |
P value | 0.064 | 0.379 | ||
PHI (1.393 ± 0.52 m/sec) | ||||
Baseline | 3.915 ± 0.973 | 3.080 ± 0.610 | 2.827 | 0.007* |
30 days after | 3.605 ± 1.168 | 3.000 ± 0.858 | 1.867 | 0.070 |
P value | 0.024* | 0.528 | ||
LVI (11.71 ± 2.9 cm/sec) | ||||
Baseline | 6.420 ± 2.561 | 6.140 ± 2.011 | 0.385 | 0.703 |
30 days after | 7.094 ± 2.135 | 5.630 ± 2.640 | 1.928 | 0.061 |
P value | 0.188 | 0.280 | ||
MLVI (43.8 ± 7.2 cm/sec) | ||||
Baseline | 11.540 ± 3.266 | 12.170 ± 3.506 | -0.588 | 0.560 |
30 days after | 13.305 ± 3.222 | 11.000 ± 2.968 | 2.353 | 0.024* |
P value | 0.009* | 0.100 | ||
SARI (0.57 ± 0.04) | ||||
Baseline | 0.697 ± 0.073 | 0.609 ± 0.101 | 3.177 | 0.003* |
30 days after | 0.668 ± 0.083 | 0.615 ± 0.096 | 1.853 | 0.072 |
P value | 0.231 | 0.767 |
PVD: Portal vein diameter, PVV: Portal vein velocity, PVFV, HARI: Hepatic artery resistance index, HAPI: Hepatic artery pulsatility index, PHI: Portal hypertension index, LVI: Liver vascular index, MLVI: Modified liver vascular index, SARI: Splenic artery resistance index